SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-24-002532
Filing Date
2024-11-08
Accepted
2024-11-08 18:51:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13ga510022atnm_11082024.htm SC 13G/A 230450
  Complete submission text file 0000921895-24-002532.txt   232100
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Subject) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82467 | Film No.: 241442471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11700 W CHARLESTON BLVD 170-659 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD 170-659 LAS VEGAS NV 89135 631-987-0235
Bigger Capital, LLC (Filed by) CIK: 0001996245 (see all company filings)

IRS No.: 900131168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A